Loading clinical trials...
Loading clinical trials...
A Medium Chain Triglyceride INTervention for Alzheimer Disease (A MINT for AD)
Conditions
Interventions
Ketogenic medium chain triglyceride drink (MCT drink)
Placebo
Locations
1
Canada
Djavad Mowafaghian Centre for Brain Health
Vancouver, British Columbia, Canada
Start Date
September 1, 2016
Primary Completion Date
February 4, 2020
Completion Date
March 1, 2020
Last Updated
April 23, 2026
NCT07033494
NCT06159673
NCT07457138
NCT07422857
NCT07214727
NCT06584357
Lead Sponsor
University of British Columbia
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions